171 related articles for article (PubMed ID: 37768813)
81. Psychometric Evaluation of the Bahasa Malaysia Version of the Lymphedema Functioning, Disability, and Health Questionnaire for Upper Limb Lymphedema in Patients with Breast Cancer-Related Lymphedema.
Meilani E; Zanudin A; Nordin NAM
Lymphat Res Biol; 2024 Jun; 22(3):210-220. PubMed ID: 38608242
[No Abstract] [Full Text] [Related]
82. Clinical feasibility of Axillary Reverse Mapping and its influence on breast cancer related lymphedema: a systematic review.
Gebruers N; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():117-22. PubMed ID: 27019287
[TBL] [Abstract][Full Text] [Related]
83. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies.
Shah C; Vicini FA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):907-14. PubMed ID: 21945108
[TBL] [Abstract][Full Text] [Related]
84. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial.
Schmitz KH; Ahmed RL; Troxel AB; Cheville A; Lewis-Grant L; Smith R; Bryan CJ; Williams-Smith CT; Chittams J
JAMA; 2010 Dec; 304(24):2699-705. PubMed ID: 21148134
[TBL] [Abstract][Full Text] [Related]
85. The Development of Breast Cancer-Related Lymphedema After Mastectomy in a Rural Population.
Clegg DJ; Whiteaker EN; Salomon BJ; Brooks AJ; Bell JL; Boukovalas S; Roberson PNE; Lloyd JM
Am Surg; 2023 Aug; 89(8):3591-3593. PubMed ID: 36921062
[TBL] [Abstract][Full Text] [Related]
86. Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience.
Yang EJ; Ahn S; Kim EK; Kang E; Park Y; Lim JY; Kim SW
Breast Cancer Res Treat; 2016 Nov; 160(2):269-276. PubMed ID: 27665585
[TBL] [Abstract][Full Text] [Related]
87. Use of bioimpedance spectroscopy for prospective surveillance and early diagnosis of breast cancer-related lymphedema.
Forte AJ; Huayllani MT; Boczar D; Avila FR; Kassis S; Ciudad P; Lu X; Moore PA; McLaughlin SA
Breast Dis; 2021; 40(2):85-93. PubMed ID: 33646139
[TBL] [Abstract][Full Text] [Related]
88. Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.
Cariati M; Bains SK; Grootendorst MR; Suyoi A; Peters AM; Mortimer P; Ellis P; Harries M; Van Hemelrijck M; Purushotham AD
Br J Surg; 2015 Aug; 102(9):1071-8. PubMed ID: 26040263
[TBL] [Abstract][Full Text] [Related]
89. Burden of lymphedema in long-term breast cancer survivors by race and age.
Ren Y; Kebede MA; Ogunleye AA; Emerson MA; Evenson KR; Carey LA; Hayes SC; Troester MA
Cancer; 2022 Dec; 128(23):4119-4128. PubMed ID: 36223240
[TBL] [Abstract][Full Text] [Related]
90. Lymphedema After Axillary Lymph Node Dissection in Breast Cancer: Prevalence and Risk Factors-A Single-Center Retrospective Study.
Hara Y; Otsubo R; Shinohara S; Morita M; Kuba S; Matsumoto M; Yamanouchi K; Yano H; Eguchi S; Nagayasu T
Lymphat Res Biol; 2022 Dec; 20(6):600-606. PubMed ID: 35357959
[No Abstract] [Full Text] [Related]
91. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors.
Fu MR; Chen CM; Haber J; Guth AA; Axelrod D
Ann Surg Oncol; 2010 Jul; 17(7):1847-53. PubMed ID: 20140528
[TBL] [Abstract][Full Text] [Related]
92. Breast cancer-related lymphedema: women's experiences with an underestimated condition.
Thomas-MacLean R; Miedema B; Tatemichi SR
Can Fam Physician; 2005 Feb; 51(2):246-7. PubMed ID: 16926934
[TBL] [Abstract][Full Text] [Related]
93. Early Disturbance of Lymphatic Transport as a Risk Factor for the Development of Breast-Cancer-Related Lymphedema.
Thomis S; Devoogdt N; Bechter-Hugl B; Fourneau I
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980660
[TBL] [Abstract][Full Text] [Related]
94. Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort.
Swaroop MN; Ferguson CM; Horick NK; Skolny MN; Miller CL; Jammallo LS; Brunelle CL; O'Toole JA; Isakoff SJ; Specht MC; Taghian AG
Breast Cancer Res Treat; 2015 Jun; 151(2):393-403. PubMed ID: 25940996
[TBL] [Abstract][Full Text] [Related]
95. Breast cancer-related lymphedema correlated with incidence of cellulitis and mortality.
Cheng MH; Ho OA; Tsai TJ; Lin YL; Kuo CF
J Surg Oncol; 2022 Dec; 126(7):1162-1168. PubMed ID: 35960614
[TBL] [Abstract][Full Text] [Related]
96. Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB.
Belmonte R; Messaggi-Sartor M; Ferrer M; Pont A; Escalada F
Support Care Cancer; 2018 Sep; 26(9):3277-3287. PubMed ID: 29651594
[TBL] [Abstract][Full Text] [Related]
97. Constitutively Enhanced Lymphatic Pumping in the Upper Limbs of Women Who Later Develop Breast Cancer-Related Lymphedema.
Cintolesi V; Stanton AW; Bains SK; Cousins E; Peters AM; Purushotham AD; Levick JR; Mortimer PS
Lymphat Res Biol; 2016 Jun; 14(2):50-61. PubMed ID: 27309032
[TBL] [Abstract][Full Text] [Related]
98. Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies.
Shen A; Lu Q; Fu X; Wei X; Zhang L; Bian J; Qiang W; Pang D
Support Care Cancer; 2022 Dec; 31(1):18. PubMed ID: 36513801
[TBL] [Abstract][Full Text] [Related]
99. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
100. Diagnostic Criteria for Breast Cancer-Related Lymphedema of the Upper Extremity: The Need for Universal Agreement.
Kassamani YW; Brunelle CL; Gillespie TC; Bernstein MC; Bucci LK; Nassif T; Taghian AG
Ann Surg Oncol; 2022 Feb; 29(2):989-1002. PubMed ID: 34505218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
